File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1002/hon.2900100302
- Scopus: eid_2-s2.0-0026715203
- PMID: 1398509
- WOS: WOS:A1992JU20700001
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: The prognostic factors for peripheral T-cell lymphomas
Title | The prognostic factors for peripheral T-cell lymphomas |
---|---|
Authors | |
Keywords | Non‐Hodgkin's lymphoma T‐immunophenotype |
Issue Date | 1992 |
Publisher | John Wiley & Sons Ltd. The Journal's web site is located at http://www3.interscience.wiley.com/cgi-bin/jhome/3182 |
Citation | Hematological Oncology, 1992, v. 10 n. 3-4, p. 135-140 How to Cite? |
Abstract | The peripheral T-cell lymphomas of 50 patients were classified by histological type and tumour cell size, the latter as described by the Nebraska Group. There was no difference in the pattern of their clinical features among the various histological subtypes and their clinical outcome was similar. Cell size and other factors including sex, age, presence of B symptoms, sites of primary disease, histological subtypes according to the Japanese classification, lactate dehydrogenase level and presence of bulky disease did not appear to correlate with clinical outcome. However, patients with stage IV disease had significantly lower CR rate (9/29 versus 16/21, p = 0.01) and poorer survival at 3 years (p = 0.05) than those with stage I, II and III disease. Patients receiving COPP, the less intensive chemotherapy regimen, appeared to have poorer clinical outcome but the difference observed was not statistically significant because of the number of patients in each subgroup. |
Persistent Identifier | http://hdl.handle.net/10722/161944 |
ISSN | 2023 Impact Factor: 3.3 2023 SCImago Journal Rankings: 0.820 |
ISI Accession Number ID |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Liang, R | en_US |
dc.contributor.author | Loke, SL | en_US |
dc.contributor.author | Chan, ACL | en_US |
dc.date.accessioned | 2012-09-05T05:16:12Z | - |
dc.date.available | 2012-09-05T05:16:12Z | - |
dc.date.issued | 1992 | en_US |
dc.identifier.citation | Hematological Oncology, 1992, v. 10 n. 3-4, p. 135-140 | en_US |
dc.identifier.issn | 0278-0232 | en_US |
dc.identifier.uri | http://hdl.handle.net/10722/161944 | - |
dc.description.abstract | The peripheral T-cell lymphomas of 50 patients were classified by histological type and tumour cell size, the latter as described by the Nebraska Group. There was no difference in the pattern of their clinical features among the various histological subtypes and their clinical outcome was similar. Cell size and other factors including sex, age, presence of B symptoms, sites of primary disease, histological subtypes according to the Japanese classification, lactate dehydrogenase level and presence of bulky disease did not appear to correlate with clinical outcome. However, patients with stage IV disease had significantly lower CR rate (9/29 versus 16/21, p = 0.01) and poorer survival at 3 years (p = 0.05) than those with stage I, II and III disease. Patients receiving COPP, the less intensive chemotherapy regimen, appeared to have poorer clinical outcome but the difference observed was not statistically significant because of the number of patients in each subgroup. | en_US |
dc.language | eng | en_US |
dc.publisher | John Wiley & Sons Ltd. The Journal's web site is located at http://www3.interscience.wiley.com/cgi-bin/jhome/3182 | en_US |
dc.relation.ispartof | Hematological Oncology | en_US |
dc.subject | Non‐Hodgkin's lymphoma | - |
dc.subject | T‐immunophenotype | - |
dc.subject.mesh | Age Factors | en_US |
dc.subject.mesh | Female | en_US |
dc.subject.mesh | Hong Kong - Epidemiology | en_US |
dc.subject.mesh | Humans | en_US |
dc.subject.mesh | Immunophenotyping | en_US |
dc.subject.mesh | L-Lactate Dehydrogenase - Analysis | en_US |
dc.subject.mesh | Lymphoma, T-Cell, Peripheral - Classification - Epidemiology - Pathology | en_US |
dc.subject.mesh | Male | en_US |
dc.subject.mesh | Middle Aged | en_US |
dc.subject.mesh | Neoplasm Staging | en_US |
dc.subject.mesh | Prognosis | en_US |
dc.subject.mesh | Sex Factors | en_US |
dc.subject.mesh | Tumor Markers, Biological - Analysis | en_US |
dc.title | The prognostic factors for peripheral T-cell lymphomas | en_US |
dc.type | Article | en_US |
dc.identifier.email | Liang, R:rliang@hku.hk | en_US |
dc.identifier.authority | Liang, R=rp00345 | en_US |
dc.description.nature | link_to_subscribed_fulltext | en_US |
dc.identifier.doi | 10.1002/hon.2900100302 | en_US |
dc.identifier.pmid | 1398509 | - |
dc.identifier.scopus | eid_2-s2.0-0026715203 | en_US |
dc.identifier.volume | 10 | en_US |
dc.identifier.issue | 3-4 | en_US |
dc.identifier.spage | 135 | en_US |
dc.identifier.epage | 140 | en_US |
dc.identifier.isi | WOS:A1992JU20700001 | - |
dc.publisher.place | United Kingdom | en_US |
dc.identifier.scopusauthorid | Liang, R=26643224900 | en_US |
dc.identifier.scopusauthorid | Loke, SL=7006559512 | en_US |
dc.identifier.scopusauthorid | Chan, ACL=16047349300 | en_US |
dc.identifier.issnl | 0278-0232 | - |